Alkermes plc (ALKS) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alkermes plc Reports First Quarter 2016 Financial Results
April 28, 2016 7:00 AM EDTFirst Quarter Revenues of $157 Million, GAAP Loss per Share of $0.51 and Non-GAAP Loss per Share of $0.16
VIVITROL® Net Sales Grew by 41% Year-Over-Year to $43.8 Million
ARISTADA® Gaining Traction in Growing Long-Acting Antipsychotic Market
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ: ALKS) today reported financial results for... More
